Literature DB >> 7807022

Activation of the p21ras pathway couples antigen receptor stimulation to induction of the primary response gene egr-1 in B lymphocytes.

S B McMahon1, J G Monroe.   

Abstract

The primary response gene egr-1 encodes a sequence-specific transcription factor whose expression is necessary for antigen receptor-stimulated activation of B lymphocytes. The molecular processes involved in linking egr-1 induction to antigen receptor signaling have not been defined. The present study demonstrates that expression of an activated form of p21ras results in egr-1 induction similar to that previously shown after antigen receptor cross-linking. In addition, both antigen receptor cross-linking and p21ras use the same element in the egr-1 promoter to exert their effects. Using dominant-negative mutants of p21ras and raf-1, we demonstrate that induction of egr-1 after antigen receptor cross-linking is mediated by activation of the p21ras/mitogen-activated protein kinase signaling pathway. While regulation of the p21ras pathway during B cell activation has been intensively studied, this report represents the first description of a biologically relevant event associated with its activation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7807022      PMCID: PMC2191844          DOI: 10.1084/jem.181.1.417

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  33 in total

1.  B cell antigen receptor cross-linking triggers rapid protein kinase C independent activation of p21ras1.

Authors:  A E Harwood; J C Cambier
Journal:  J Immunol       Date:  1993-11-01       Impact factor: 5.422

2.  Evidence that activation of the Egr-1 promoter by v-Raf involves serum response elements.

Authors:  M Rim; S A Qureshi; D Gius; J Nho; V P Sukhatme; D A Foster
Journal:  Oncogene       Date:  1992-10       Impact factor: 9.867

3.  Tyrosine phosphorylation of the vav proto-oncogene product in activated B cells.

Authors:  X R Bustelo; M Barbacid
Journal:  Science       Date:  1992-05-22       Impact factor: 47.728

4.  Raf-1 activates MAP kinase-kinase.

Authors:  J M Kyriakis; H App; X F Zhang; P Banerjee; D L Brautigan; U R Rapp; J Avruch
Journal:  Nature       Date:  1992-07-30       Impact factor: 49.962

5.  Targets of B lymphocyte antigen receptor signal transduction include the p21ras GTPase-activating protein (GAP) and two GAP-associated proteins.

Authors:  M R Gold; M T Crowley; G A Martin; F McCormick; A L DeFranco
Journal:  J Immunol       Date:  1993-01-15       Impact factor: 5.422

6.  Phosphorylation of c-jun mediated by MAP kinases.

Authors:  B J Pulverer; J M Kyriakis; J Avruch; E Nikolakaki; J R Woodgett
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

7.  Direct stimulation of Vav guanine nucleotide exchange activity for Ras by phorbol esters and diglycerides.

Authors:  E Gulbins; K M Coggeshall; G Baier; D Telford; C Langlet; G Baier-Bitterlich; N Bonnefoy-Berard; P Burn; A Wittinghofer; A Altman
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

8.  Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase).

Authors:  D M Payne; A J Rossomando; P Martino; A K Erickson; J H Her; J Shabanowitz; D F Hunt; M J Weber; T W Sturgill
Journal:  EMBO J       Date:  1991-04       Impact factor: 11.598

9.  Raf-1 is required for T cell IL2 production.

Authors:  H Owaki; R Varma; B Gillis; J T Bruder; U R Rapp; L S Davis; T D Geppert
Journal:  EMBO J       Date:  1993-11       Impact factor: 11.598

10.  p21ras couples the T cell antigen receptor to extracellular signal-regulated kinase 2 in T lymphocytes.

Authors:  M Izquierdo; S J Leevers; C J Marshall; D Cantrell
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

View more
  17 in total

1.  PTP-PEST, a scaffold protein tyrosine phosphatase, negatively regulates lymphocyte activation by targeting a unique set of substrates.

Authors:  D Davidson; A Veillette
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

2.  Diacylglycerol kinase ζ limits B cell antigen receptor-dependent activation of ERK signaling to inhibit early antibody responses.

Authors:  Matthew L Wheeler; Matthew B Dong; Robert Brink; Xiao-Ping Zhong; Anthony L DeFranco
Journal:  Sci Signal       Date:  2013-10-15       Impact factor: 8.192

3.  MAPkinase: a second site of G-protein regulation of B-cell activation via the antigen receptors.

Authors:  M R Deehan; G G Klaus; M J Holman; W Harnett; M M Harnett
Journal:  Immunology       Date:  1998-10       Impact factor: 7.397

4.  Wanderings in biochemistry.

Authors:  Peter Lengyel
Journal:  J Biol Chem       Date:  2014-05-27       Impact factor: 5.157

5.  Shc contains two Grb2 binding sites needed for efficient formation of complexes with SOS in B lymphocytes.

Authors:  S L Harmer; A L DeFranco
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

6.  Role of EGR1 in regulation of stimulus-dependent CD44 transcription in B lymphocytes.

Authors:  J S Maltzman; J A Carman; J G Monroe
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

7.  Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1.

Authors:  M Bouaboula; C Poinot-Chazel; B Bourrié; X Canat; B Calandra; M Rinaldi-Carmona; G Le Fur; P Casellas
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

8.  Molecular remodelling in hypertrophied hearts from polyomavirus large T-antigen transgenic mice.

Authors:  E L Holder; A E Al Moustafa; L E Chalifour
Journal:  Mol Cell Biochem       Date:  1995-11-22       Impact factor: 3.396

Review 9.  p204, a p200 family protein, as a multifunctional regulator of cell proliferation and differentiation.

Authors:  Yi Luan; Peter Lengyel; Chuan-Ju Liu
Journal:  Cytokine Growth Factor Rev       Date:  2008-11-21       Impact factor: 7.638

10.  Prostaglandin E2 regulates B cell proliferation through a candidate tumor suppressor, Ptger4.

Authors:  Jernej Murn; Olivier Alibert; Ning Wu; Simon Tendil; Xavier Gidrol
Journal:  J Exp Med       Date:  2008-12-15       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.